help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HANSEN, E. F.
Right arrow Articles by DIRKSEN, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HANSEN, E. F.
Right arrow Articles by DIRKSEN, A.

Am. J. Respir. Crit. Care Med., Volume 159, Number 4, April 1999, 1267-1271

Reversible and Irreversible Airflow Obstruction as Predictor of Overall Mortality in Asthma and Chronic Obstructive Pulmonary Disease

EJVIND FRAUSING HANSEN, KLAUS PHANARETH, LARS C. LAURSEN, AXEL KOK-JENSEN, and ASGER DIRKSEN

Department of Pulmonary Medicine, Copenhagen University Hospital, Gentofte; and Department of Respiratory Medicine, Rigshospitalet, Copenhagen, Denmark

The importance of reversible airflow obstruction to the prognosis of asthma and chronic obstructive pulmonary disease (COPD) is not clear. We tested the hypothesis that reversibility to corticosteroid and bronchodilator is not an independent predictor of prognosis, but merely reflects a component of the maximal attainable lung function, which is the best spirometric predictor of survival. During a 6-yr period (1983-1988), 1,586 subjects with asthma or COPD underwent standardized bronchodilator and corticosteroid reversibility tests at a chest clinic in Copenhagen. The vital status was obtained by September 1997. The relationship between mortality and age, gender, smoking, FEV1, and reversibilities was examined by Cox proportional hazards analyses. Of 1,586 subjects, 850 had died before September 1997. Age, smoking, and FEV1 were significant predictors of mortality. After controlling for baseline FEV1, bronchodilator and corticosteroid reversibility were significantly associated with better survival. However, after controlling for best FEV1 all reversibilities became nonsignificant and nonpredictive. The combined use of corticosteroid and bronchodilator reversibility in survival analyses is a novel approach, and we have shown that both contribute to survival prediction to the extent that they modify FEV1. However, reversibility per se does not influence survival in subjects with moderate to severe asthma or COPD.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
C. J. Jolley, Y-M. Luo, J. Steier, C. Reilly, J. Seymour, A. Lunt, K. Ward, G. F. Rafferty, M. I. Polkey, and J. Moxham
Neural respiratory drive in healthy subjects and in COPD
Eur. Respir. J., February 1, 2009; 33(2): 289 - 297.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. H. van Veen, A. ten Brinke, P. J. Sterk, J. K. Sont, S. A. Gauw, K. F. Rabe, and E. H. Bel
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Eur. Respir. J., August 1, 2008; 32(2): 344 - 349.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. M. Mannino
Coexisting Asthma and COPD: Confused Clinicians or Poor Prognosticator?
Chest, July 1, 2008; 134(1): 1 - 2.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J. B. Soriano and D. M. Mannino
Reversing concepts on COPD irreversibility
Eur. Respir. J., April 1, 2008; 31(4): 695 - 696.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J., February 1, 2008; 31(2): 416 - 469.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
Y.-C. Wang, J.-M. Lin, C.-Y. Li, L.-T. Lee, Y.-L. Guo, and F.-C. Sung
Prevalence and Risks of Chronic Airway Obstruction: A Population Cohort Study in Taiwan
Chest, March 1, 2007; 131(3): 705 - 710.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
IlonkaH. van Veen, PieterS. Hiemstra, A. ten Brinke, A. Roos, RenateM. Verhoosel, JaapK. Sont, PeterJ. Sterk, KlausF. Rabe, and ElisabethH. Bel
Mannose binding lectin (MBL) levels predict lung function decline in severe asthma
Eur. Respir. Rev., December 1, 2006; 15(101): 224 - 225.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
D M Mannino
Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story.
Thorax, December 1, 2006; 61(12): 1032 - 1034.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. J. Martinez, G. Foster, J. L. Curtis, G. Criner, G. Weinmann, A. Fishman, M. M. DeCamp, J. Benditt, F. Sciurba, B. Make, et al.
Predictors of Mortality in Patients with Emphysema and Severe Airflow Obstruction
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1326 - 1334.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. M. Mannino, G. Watt, D. Hole, C. Gillis, C. Hart, A. McConnachie, G. Davey Smith, M. Upton, V. Hawthorne, D. D. Sin, et al.
The natural history of chronic obstructive pulmonary disease.
Eur. Respir. J., March 1, 2006; 27(3): 627 - 643.
[Full Text] [PDF]

Home page
 CMAJHome page
G. Knoll, S. Cockfield, T. Blydt-Hansen, D. Baran, B. Kiberd, D. Landsberg, D. Rush, E. Cole, and for The Kidney Transplant Working Group of the Can
Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation
Can. Med. Assoc. J., November 8, 2005; 173(10): S1 - S25.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Hoogendoorn, M. P. M. H. Rutten-van Molken, R. T. Hoogenveen, M. L. L. van Genugten, A. S. Buist, E. F. M. Wouters, and T. L. Feenstra
A dynamic population model of disease progression in COPD
Eur. Respir. J., August 1, 2005; 26(2): 223 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. F. Hansen and J. Vestbo
Bronchodilator reversibility in COPD: the roguish but harmless little brother of airway hyperresponsiveness?
Eur. Respir. J., July 1, 2005; 26(1): 6 - 7.
[Full Text] [PDF]

Home page
 ChestHome page
A. Lindberg, A.-C. Jonsson, E. Ronmark, R. Lundgren, L.-G. Larsson, and B. Lundback
Ten-Year Cumulative Incidence of COPD and Risk Factors for Incident Disease in a Symptomatic Cohort
Chest, May 1, 2005; 127(5): 1544 - 1552.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. J. van der Woude, J. Zaagsma, D. S. Postma, T. H. Winter, M. van Hulst, and R. Aalbers
Detrimental Effects of {beta}-Blockers in COPD: A Concern for Nonselective {beta}-Blockers
Chest, March 1, 2005; 127(3): 818 - 824.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. P. Hersh, D. L. DeMeo, E. Al-Ansari, V. J. Carey, J. J. Reilly, L. C. Ginns, and E. K. Silverman
Predictors of Survival in Severe, Early Onset COPD
Chest, November 1, 2004; 126(5): 1443 - 1451.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. H. Groenewegen, A. M.W.J. Schols, and E. F.M. Wouters
Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD
Chest, August 1, 2003; 124(2): 459 - 467.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P M A Calverley, P S Burge, S Spencer, J A Anderson, and P W Jones
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
Thorax, August 1, 2003; 58(8): 659 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Miravitlles
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Eur. Respir. J., July 1, 2002; 20(36_suppl): 9S - 19s.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. M. Mannino
COPD* : Epidemiology, Prevalence, Morbidity and Mortality, and Disease Heterogeneity
Chest, May 1, 2002; 121(5_suppl): 121S - 126S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C.K. Connolly, S.M. Alcock, and R.J. Prescott
Mortality in asthmatics over 15 yrs: a dynamic cohort study from 1983-1998
Eur. Respir. J., April 1, 2002; 19(4): 593 - 598.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. ten BRINKE, A. H. ZWINDERMAN, P. J. STERK, K. F. RABE, and E. H. BEL
Factors Associated with Persistent Airflow Limitation in Severe Asthma
Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 744 - 748.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J Vestbo and E F Hansen
Airway hyperresponsiveness and COPD mortality
Thorax, September 1, 2001; 56(90002): ii11 - 14.
[Full Text] [PDF]

Home page
 ThoraxHome page
J C Kips and R A Pauwels
Low dose inhaled corticosteroids and the prevention of death from asthma
Thorax, September 1, 2001; 56(90002): ii74 - 78.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Miravitlles, C. Murio, and T. Guerrero
Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis
Eur. Respir. J., May 1, 2001; 17(5): 928 - 933.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.M. Anto, P. Vermeire, J. Vestbo, and J. Sunyer
Epidemiology of chronic obstructive pulmonary disease
Eur. Respir. J., May 1, 2001; 17(5): 982 - 994.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. A. H. Wijnhoven, D. M. W. Kriegsman, A. E. Hesselink, B. W. J. H. Penninx, and M. de Haan
Determinants of Different Dimensions of Disease Severity in Asthma and COPD : Pulmonary Function and Health-Related Quality of Life
Chest, April 1, 2001; 119(4): 1034 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. F. HANSEN, J. VESTBO, K. PHANARETH, A. KOK-JENSEN, and A. DIRKSEN
Peak Flow as Predictor of Overall Mortality in Asthma and Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 690 - 693.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society 		  CCM abstracts